Genome BC-led Strategic Fund Supports Biomedical, Environmental Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – Genome British Columbia has awarded a total of C$2 million (US$1.9 million) to support seven projects that will use a range of genomics for human health, biomedicine, and biology research.

The new projects, all located in BC, were funded under the Strategic Opportunities Fund (SOF), an initiative supported by Genome BC and several partners that seeks to catalyze new initiatives in areas of strategic importance to the BC region. These investments generally provide money for foundational research projects that will create a basis for future studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.

Sep
17
Sponsored by
Omicia

This online seminar will provide examples of how commercial and hospital-affiliated clinical labs are successfully developing and deploying high-throughput next-generation sequencing-based testing services for genetic diseases. 

Sep
24
Sponsored by
Personalis

This online seminar will outline a targeted enrichment technology to improve next-generation sequencing assays for cancer research and clinical applications. 

Oct
01
Sponsored by
Swift Biosciences

This webinar will discuss a new library preparation method that enables complete methylome characterization from only about 20 starting cells.

Oct
07
Sponsored by
Personal Genome Diagnostics

This webinar will highlight the key considerations and applications of next-generation sequencing for managing non-small cell lung cancer patients using plasma-based approaches.